NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Up 311.9% in May

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totaling 64,064 shares, an increase of 311.9% from the April 30th total of 15,554 shares. Based on an average daily volume of 2,648,206 shares, the days-to-cover ratio is presently 0.0 days. Approximately 38.1% of the shares of the company are sold short.

NewGenIvf Group Price Performance

NASDAQ:NIVF traded down $0.12 during mid-day trading on Friday, reaching $0.91. 6,122,327 shares of the company’s stock were exchanged, compared to its average volume of 6,701,081. NewGenIvf Group has a one year low of $0.72 and a one year high of $1,839.00. The business’s fifty day simple moving average is $1.65 and its two-hundred day simple moving average is $6.70. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98.

NewGenIvf Group (NASDAQ:NIVF) last released its quarterly earnings results on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The company had revenue of $1.42 million for the quarter. Analysts forecast that NewGenIvf Group will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Insider Buying and Selling

In related news, major shareholder Financial Lp Hrt acquired 137,541 shares of NewGenIvf Group stock in a transaction on Friday, May 22nd. The stock was purchased at an average cost of $0.99 per share, with a total value of $136,165.59. Following the completion of the transaction, the insider directly owned 111,885 shares in the company, valued at $110,766.15. This trade represents a -536.10% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 31.80% of the stock is currently owned by company insiders.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.